If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capi ...

Investors might want to bet on Tenet Healthcare (THC) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The powe ...

Tenet Healthcare (THC) closed at $129.64 in the latest trading session, marking a +0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq added 0.98%.The hospital operator's shares have seen a decrease of 9.87% over the last month, not keeping up with the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34%.Market participants will be closely following the financial results of Ten ...

AI-Related Sectors in the US Economy - The US economy is experiencing a secular uptrend in sectors connected with AI [1] Tenet Healthcare Corporation (THC) - The article discusses reasons why Tenet Healthcare Corporation (THC) is worth considering, though specific reasons are not detailed in the provided content [1] Analyst's Position on THC - The analyst holds a beneficial long position in THC through stock ownership, options, or other derivatives [2] - The article reflects the analyst's personal opinions and is not influenced by compensation or business relationships with mentioned companies [2]

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) .Tenet currently has an average brokerage recommendation (ABR) of 1.32, ...

U.S. healthcare services company Tenet Healthcare Corporation (THC) declined 15.3% in the past month, underperforming the hospital industry and the S&P 500 Index. In comparison, its peers, HCA Healthcare, Inc. (HCA) and Select Medical Holdings Corporation (SEM) , have slipped 10.8% and 44.7%, respectively, during this time.The hospital industry is facing some challenges. Analysts expect that the new administration’s focus on cutting government spending and implementing changes could impact hospital profits ...

Core Viewpoint - Tenet Healthcare reported strong Q3 2024 earnings, with adjusted EPS of $2.93, exceeding estimates and more than doubling year-over-year, indicating robust operational performance despite recent stock underperformance [2][4]. Financial Performance - Adjusted net income reached $282 million, an increase of 84.3% year-over-year, surpassing management's expectations [4]. - Net operating revenues grew 1.1% year-over-year to $5.12 billion, exceeding management's guidance and consensus estimates [2][3]. - Adjusted EBITDA increased 14.5% year-over-year to $978 million, driven by improved same-hospital admissions and a favorable payer mix [5]. Segment Analysis - Hospital Operations and Services segment reported net operating revenues of $3.98 billion, down 3.4% year-over-year due to hospital divestitures, but same-hospital revenues improved by 6.1% [7]. - Ambulatory Care segment saw net operating revenues rise 21% year-over-year to $1.14 billion, attributed to facility buyouts and service line expansions [9]. Cost Management - Total operating costs decreased nearly 10% year-over-year to $4.1 billion, aided by lower salaries and higher net gains from facility sales [6]. Financial Position - As of September 30, 2024, Tenet had cash and cash equivalents of $4.1 billion, a significant increase from the previous year [12]. - Total assets rose to $29.4 billion, while long-term debt decreased by 14.2% to $12.8 billion [13]. Shareholder Returns - The company repurchased $124 million in common shares during Q3 [15]. Future Outlook - For Q4 2024, net operating revenues are projected between $5 billion and $5.2 billion, with adjusted EBITDA expected to range from $953 million to $1.05 billion [16]. - For the full year 2024, net operating revenues are forecasted between $20.6 billion and $20.8 billion, indicating a slight growth from 2023 [17]. Estimate Revisions - There has been an upward trend in earnings estimates, with a consensus shift of 7.47% in the past month [22][23]. Investment Sentiment - Tenet holds a Zacks Rank 1 (Strong Buy), reflecting positive investor sentiment and expectations for above-average returns in the coming months [25].

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of ...

Shares of Tenet Healthcare (THC) have gained 2.8% over the past four weeks to close the last trading session at $143.63, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $187.26 indicates a potential upside of 30.4%.The average comprises 19 short-term price targets ranging from a low of $153 to a high of $217, with a standard deviation of $15.55. While the lowest estimate indicat ...

Core Viewpoint - Tenet Healthcare Corporation reported strong Q3 2024 results, leading to a 19.6% increase in stock price, reflecting investor optimism for 2024 [1][2]. Financial Performance - Adjusted EPS of $2.93 exceeded Zacks Consensus Estimate by 25.8%, marking a 103.5% year-over-year increase [3]. - Net operating revenues rose 1.1% to $5.12 billion, surpassing expectations by 1.5% [3]. - The company anticipates adjusted EPS for 2024 to be between $11.12 and $11.73, up from previous guidance of $10.41 to $11.12, indicating a 63.7% rise from 2023 [4]. Demand and Growth Drivers - Strong demand for services is expected to persist, supported by improving labor market conditions and staffing solutions [5]. - The aging population and increasing disease prevalence are projected to sustain long-term demand for hospital services [6]. Strategic Initiatives - The company is focusing on quality assets and has divested non-core businesses to allocate capital for higher-return investments [7]. - Management's efforts aim to create a more predictable, capital-efficient business model, enhancing margins and free cash flow [8]. Technological Investments - Investments in AI-enabled technologies are expected to improve clinical and administrative workflows, reducing costs and enhancing patient experiences [9]. Market Performance - Year-to-date, THC stock has surged 120.3%, outperforming the industry and S&P 500 [10]. - The stock is trading at a forward earnings multiple of 14.48X, slightly above the industry average of 14.33X [12]. Future Outlook - The Zacks Consensus Estimate for THC's 2024 EPS suggests a 63.2% year-over-year increase, with revenue estimates indicating a 1% rise [12]. - The company is positioned for robust future growth due to strategic capacity expansion and favorable industry trends [16].